Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)

ClinicalTrials.gov ID: NCT03987074

Public ClinicalTrials.gov record NCT03987074. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 11, 2026, 4:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Proof of Concept, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Subjects With Nonalcoholic Steatohepatitis (NASH)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the safety and tolerability of study drug(s) in participants with nonalcoholic steatohepatitis (NASH).

Study identification

NCT ID: NCT03987074
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Gilead Sciences; Industry
Enrollment: 109 participants

Conditions and interventions

Conditions

Nonalcoholic Steatohepatitis

Interventions

Drug

Eligibility (public fields only)

Age range: 18 Years to 75 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 28, 2019
Primary completion: Jul 12, 2020
Completion: Jul 12, 2020
Last update posted: Jul 14, 2021

2019 – 2020

United States locations

U.S. sites: 18
U.S. states: 10
U.S. cities: 17

Facility	City	State	ZIP	Site status
Institute for Liver Health - Arizona Liver Health	Chandler	Arizona	85224	—
Southern California Research Centers	Coronado	California	92118	—
University of California San Diego (UCSD)	La Jolla	California	92093	—
Ruane Clinical Research Group, Inc	Los Angeles	California	90036	—
Cedars Sinai Medical Center	Los Angeles	California	90048	—
Inland Empire Clinical Trials, LLC	Rialto	California	92377	—
Medical Associates Research Group	San Diego	California	92123	—
Gastrointestinal Specialists of Georgia	Marietta	Georgia	30060	—
Beth Israel Deaconess Medical Center	Boston	Massachusetts	02215	—
Jubilee Clinical Research, Inc.	Las Vegas	Nevada	89109	—
Northwell Health	Manhasset	New York	11030	—
Gastro One	Huntersville	North Carolina	28078	—
University Gastroenterology	Providence	Rhode Island	02905	—
Gastro One	Germantown	Tennessee	38138	—
Quality Medical Research, PLLC	Nashville	Tennessee	37211	—
Texas Clinical Research Institute	Arlington	Texas	76012	—
The Liver Institute at Methodist Dallas Medical Center	Dallas	Texas	75203	—
American Research Corporation	San Antonio	Texas	78215	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03987074, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 14, 2021 · Synced Sep 11, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03987074 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →